Am J Perinatol 2018; 35(07): 669-675
DOI: 10.1055/s-0037-1608931
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Surfactant Administration through Laryngeal Mask Airway: A Randomized Controlled Study in Rabbits

Cristian A. Bernardo
1   Division of Neonatology, Department of Pediatrics, Hospital Italiano de Buenos Aires, Ciudad de Buenos Aires, Argentina
2   School of Medicine, Instituto Universitario, Hospital Italiano de Buenos Aires, Ciudad de Buenos Aires, Argentina
,
Gonzalo L. Mariani
1   Division of Neonatology, Department of Pediatrics, Hospital Italiano de Buenos Aires, Ciudad de Buenos Aires, Argentina
2   School of Medicine, Instituto Universitario, Hospital Italiano de Buenos Aires, Ciudad de Buenos Aires, Argentina
,
María de los Ángeles Virasoro
1   Division of Neonatology, Department of Pediatrics, Hospital Italiano de Buenos Aires, Ciudad de Buenos Aires, Argentina
,
Sebastián Burgos
3   Department of Nursing, Hospital Italiano de Buenos Aires, Ciudad de Buenos Aires, Argentina
,
María J. Labanca
4   Division of Pathology, Department of Diagnosis and Treatment, Hospital Italiano de Buenos Aires, Ciudad de Buenos Aires, Argentina
,
Pablo Otero
5   Department of Anesthesiology, Faculty of Veterinary Science, University of Buenos Aires, Buenos Aires, Argentina
› Institutsangaben
Funding The study was funded by Fundación Carlos Gianantonio, Buenos Aires, Argentina. The Curosurf vials used were received as a donation from Chiesi Farmaceutici, Parma, Italy.
Weitere Informationen

Publikationsverlauf

02. Mai 2017

31. Oktober 2017

Publikationsdatum:
08. Dezember 2017 (online)

Abstract

Background Minimally invasive techniques for surfactant administration for infants with respiratory distress syndrome (RDS) of moderate severity have been proposed. The laryngeal mask airway (LMA) helps in securing the airway without the need of laryngoscopy, but still requires the use of positive pressure ventilation (PPV) to flush surfactant into the lungs.

Objective This article compares the effectiveness of two techniques for LMA surfactant administration, instillation into the LMA lumen followed by PPV versus direct laryngeal instillation through a preinserted feeding tube inside the LMA during spontaneous respirations.

Study Design This is a randomized controlled trial (RCT) of 18 rabbits with acquired respiratory distress after lung lavage. After surfactant was given, the rabbits remained on continuous positive airway pressure (CPAP). Gas exchange parameters were assessed at baseline and at 30 minutes and lung parenchyma pathology features were analyzed.

Results Time required for surfactant administration, oxygenation improvement, and histopathologic findings did not differ between groups. The new technique decreased the need of PPV (p < 0.05).

Conclusion In this animal model, surfactant administration through a preinserted feeding tube within the LMA lumen is safe and effective while providing the benefits of a minimally invasive approach. This technique reduces the need of PPV and may prevent its potential risks.

 
  • References

  • 1 Dunn MS, Kaempf J, de Klerk A. , et al; Vermont Oxford Network DRM Study Group. Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates. Pediatrics 2011; 128 (05) e1069-e1076
  • 2 Finer NN, Carlo WA, Walsh MC. , et al; SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 2010; 362 (21) 1970-1979
  • 3 Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB. ; COIN Trial Investigators. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 2008; 358 (07) 700-708
  • 4 Schmölzer GM, Kumar M, Pichler G, Aziz K, O'Reilly M, Cheung PY. Non-invasive versus invasive respiratory support in preterm infants at birth: systematic review and meta-analysis. BMJ 2013; 347: f5980
  • 5 Fischer HS, Bührer C. Avoiding endotracheal ventilation to prevent bronchopulmonary dysplasia: a meta-analysis. Pediatrics 2013; 132 (05) e1351-e1360
  • 6 Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2012; 11: CD001456
  • 7 Verder H, Robertson B, Greisen G. , et al; Danish-Swedish Multicenter Study Group. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. N Engl J Med 1994; 331 (16) 1051-1055
  • 8 Rojas MA, Lozano JM, Rojas MX. , et al; Colombian Neonatal Research Network. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial. Pediatrics 2009; 123 (01) 137-142
  • 9 Sandri F, Plavka R, Ancora G. , et al; CURPAP Study Group. Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics 2010; 125 (06) e1402-e1409
  • 10 Isayama T, Chai-Adisaksopha C, McDonald SD. Noninvasive ventilation with vs without early surfactant to prevent chronic lung disease in preterm infants: a systematic review and meta-analysis. JAMA Pediatr 2015; 169 (08) 731-739
  • 11 Björklund LJ, Ingimarsson J, Curstedt T. , et al. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr Res 1997; 42 (03) 348-355
  • 12 Bohlin K, Bouhafs RK, Jarstrand C, Curstedt T, Blennow M, Robertson B. Spontaneous breathing or mechanical ventilation alters lung compliance and tissue association of exogenous surfactant in preterm newborn rabbits. Pediatr Res 2005; 57 (5 Pt 1): 624-630
  • 13 Attridge JT, Stewart C, Stukenborg GJ, Kattwinkel J. Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial. Am J Perinatol 2013; 30 (03) 201-206
  • 14 Dargaville PA, Aiyappan A, Cornelius A, Williams C, De Paoli AG. Preliminary evaluation of a new technique of minimally invasive surfactant therapy. Arch Dis Child Fetal Neonatal Ed 2011; 96 (04) F243-F248
  • 15 Pillow JJ, Minocchieri S. Innovation in surfactant therapy II: surfactant administration by aerosolization. Neonatology 2012; 101 (04) 337-344
  • 16 Göpel W, Kribs A, Ziegler A. , et al; German Neonatal Network. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet 2011; 378 (9803): 1627-1634
  • 17 Aguar M, Cernada M, Brugada M, Gimeno A, Gutierrez A, Vento M. Minimally invasive surfactant therapy with a gastric tube is as effective as the intubation, surfactant, and extubation technique in preterm babies. Acta Paediatr 2014; 103 (06) e229-e233
  • 18 Kribs A, Roll C, Göpel W. , et al; NINSAPP Trial Investigators. Nonintubated surfactant application vs conventional therapy in extremely preterm infants. A randomized controlled trial. JAMA Pediatr 2015; 169 (08) 723-730
  • 19 Dargaville PA, Aiyappan A, De Paoli AG. , et al. Minimally-invasive surfactant therapy in preterm infants on continuous positive airway pressure. Arch Dis Child Fetal Neonatal Ed 2013; 98 (02) F122-F126
  • 20 Brimacombe J, Gandini D, Keller C. The laryngeal mask airway for administration of surfactant in two neonates with respiratory distress syndrome. Paediatr Anaesth 2004; 14 (02) 188-190
  • 21 Trevisanuto D, Grazzina N, Ferrarese P, Micaglio M, Verghese C, Zanardo V. Laryngeal mask airway used as a delivery conduit for the administration of surfactant to preterm infants with respiratory distress syndrome. Biol Neonate 2005; 87 (04) 217-220
  • 22 Pinheiro JM, Santana-Rivas Q, Pezzano C. Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery. J Perinatol 2016; 36 (03) 196-201
  • 23 Barbosa RF, Simões E Silva AC, Silva YP. A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates. J Pediatr (Rio J) 2017; 93 (04) 343-350
  • 24 Kazakos GM, Anagnostou T, Savvas I, Raptopoulos D, Psalla D, Kazakou IM. Use of the laryngeal mask airway in rabbits: placement and efficacy. Lab Anim (NY) 2007; 36 (04) 29-34
  • 25 Bolender RP, Hyde DM, Dehoff RT. Lung morphometry: a new generation of tools and experiments for organ, tissue, cell, and molecular biology. Am J Physiol 1993; 265 (6 Pt 1): L521-L548
  • 26 Naik AS, Kallapur SG, Bachurski CJ. , et al. Effects of ventilation with different positive end-expiratory pressures on cytokine expression in the preterm lamb lung. Am J Respir Crit Care Med 2001; 164 (03) 494-498
  • 27 Polin RA, Carlo WA. ; Committee on Fetus and Newborn; American Academy of Pediatrics. Surfactant replacement therapy for preterm and term neonates with respiratory distress. Pediatrics 2014; 133 (01) 156-163
  • 28 Sweet DG, Carnielli V, Greisen G. , et al. European consensus guidelines on the management of neonatal respiratory distress syndrome - 2016 update. Neonatology 2017; 111 (02) 107-125
  • 29 Ammari A, Suri M, Milisavljevic V. , et al. Variables associated with the early failure of nasal CPAP in very low birth weight infants. J Pediatr 2005; 147 (03) 341-347
  • 30 Fuchs H, Lindner W, Leiprecht A, Mendler MR, Hummler HD. Predictors of early nasal CPAP failure and effects of various intubation criteria on the rate of mechanical ventilation in preterm infants of <29 weeks gestational age. Arch Dis Child Fetal Neonatal Ed 2011; 96 (05) F343-F347
  • 31 De Jaegere AP, van der Lee JH, Canté C, van Kaam AH. Early prediction of nasal continuous positive airway pressure failure in preterm infants less than 30 weeks gestation. Acta Paediatr 2012; 101 (04) 374-379
  • 32 Stevens TP, Harrington EW, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev 2007; 17 (04) CD003063
  • 33 Sardesai S, Biniwale M, Wertheimer F, Garingo A, Ramanathan R. Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future. Pediatr Res 2017; 81 (1-2): 240-248
  • 34 Dargaville PA. CPAP, surfactant, or both for the preterm infant: resolving the dilemma. JAMA Pediatr 2015; 169 (08) 715-717
  • 35 van der Burg PS, de Jongh FH, Miedema M, Frerichs I, van Kaam AH. Effect of minimally invasive surfactant therapy on lung volume and ventilation in preterm infants. J Pediatr 2016; 170: 67-72
  • 36 Kanmaz HG, Erdeve O, Canpolat FE, Mutlu B, Dilmen U. Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial. Pediatrics 2013; 131 (02) e502-e509
  • 37 Aldana-Aguirre JC, Pinto M, Featherstone RM, Kumar M. Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2017; 102 (01) F17-F23
  • 38 Sinclair SE, Chi E, Lin HI, Altemeier WA. Positive end-expiratory pressure alters the severity and spatial heterogeneity of ventilator-induced lung injury: an argument for cyclical airway collapse. J Crit Care 2009; 24 (02) 206-211
  • 39 Roberts KD, Lampland AL, Meyers PA, Worwa CT, Plumm BJ, Mammel MC. Laryngeal mask airway for surfactant administration in a newborn animal model. Pediatr Res 2010; 68 (05) 414-418
  • 40 Trevisanuto D, Marchetto L. Minimally invasive approaches for surfactant administration. Acta Biomed 2013; 84 (Suppl. 01) 28-31